Regulatory effects of sestrin 3 (SESN3) in BCR-ABL expressing cells.

by Eliza Vakana, Ahmet Dirim Arslan, Amy Szilard, Jessica K Altman, Leonidas C Platanias
Published 2013-01-01

The impact of FLT3 mutation clearance and treatment response after gilteritinib therapy on overall survival in patients with FLT3 mutation–positive relapsed/refractory acute myeloi...

by Jessica K. Altman, Alexander E. Perl, Jason E. Hill, Matt Rosales, Erkut Bahceci, Mark J. Levis
Published 2021-02-01

Rare myeloid sarcoma with KMT2A (MLL)-ELL fusion presenting as a vaginal wall mass

by Haiyan Bao, Juehua Gao, Yi-Hua Chen, Jessica K. Altman, Olga Frankfurt, Amanda L. Wilson, Madina Sukhanova, Qing Chen, Xinyan Lu
Published 2019-03-01

Central Role of ULK1 in Type I Interferon Signaling

by Diana Saleiro, Swarna Mehrotra, Barbara Kroczynska, Elspeth M. Beauchamp, Pawel Lisowski, Beata Majchrzak-Kita, Tushar D. Bhagat, Brady L. Stein, Brandon McMahon, Jessica K. Altman, Ewa M. Kosciuczuk, Darren P. Baker, Chunfa Jie, Nadereh Jafari, Craig B. Thompson, Ross L. Levine, Eleanor N. Fish, Amit K. Verma, Leonidas C. Platanias
Published 2015-04-01

Intensive versus less-intensive antileukemic therapy in older adults with acute myeloid leukemia: A systematic review.

by Yaping Chang, Gordon H Guyatt, Trevor Teich, Jamie L Dawdy, Shaneela Shahid, Jessica K Altman, Richard M Stone, Mikkael A Sekeres, Sudipto Mukherjee, Thomas W LeBlanc, Gregory A Abel, Christopher S Hourigan, Mark R Litzow, Laura C Michaelis, Shabbir M H Alibhai, Pinkal Desai, Rena Buckstein, Janet MacEachern, Romina Brignardello-Petersen
Published 2021-01-01